Tailoring cancer chemoprevention regimens to the individual

Journal of Cellular Biochemistry

Volumn 91, Issue 2, 2004, Pages 277-286

  Conney, Allan H ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b Department of Cancer and Leukemia Research ^*  (United States)

Author keywords

Cancer causation; Cancer chemoprevention; Carcinogenesis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; CALCIUM; FINASTERIDE; FLUOROURACIL; LETROZOLE; SUNSCREEN; TAMOXIFEN;

BREAST CANCER; CANCER; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CANCER; ENVIRONMENTAL FACTOR; HIGH RISK POPULATION; HUMAN; INFECTION; LIFESTYLE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SKIN CANCER; SUNLIGHT; VACCINATION; ANIMAL; DISEASE MODEL; FEMALE; MALE; METHODOLOGY; MOUSE; NEOPLASM; RISK FACTOR;

ANIMALIA;

ANIMALS; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LIFE STYLE; MALE; MICE; NEOPLASMS; RISK FACTORS;

EID: 2342558614     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20001     Document Type: Review

References (64)

1. Bailey GS, Hendricks JD, Shelton DW, Nixon JE, Pawlowski NE. 1987. Enhancement of carcinogenesis by the natural anticarcinogen indole-3-carbinol. J Natl Cancer Inst 78:931-934.
2. Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, Beck GJ, Greenberg ER. 2003. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: Results of a randomized trial. J Natl Cancer Inst 95:717-722.
3. Beral V, Banks E, Reeves G. 2002. Evidence from randomised trials on the long-term effects of hormone replacement therapy [Comment]. Lancet 360:942-944.
4. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY. 1993. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85:1483-1492.
5. Conney AH. 2003. Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: The seventh DeWitt S. Goodman lecture. Cancer Res 63:7005-7031.
6. Conney AH, Lou Y-R, Xie J-G, Osawa T, Newmark HL, Liu Y, Chang RL, Huang M-T. 1997. Some perspectives on dietary inhibition of carcinogenesis: Studies with curcumin and tea. Proc Soc Exp Biol Med 216:234-245.
7. Dashwood RH. 1998. Indole-3-carbinol: Anticarcinogen or tumor promoter in Brassica vegetables? Chem Biol Interact 110:1-5.
8. 1 carcinogenesis by the natural tumor modulator indole-3-carbinol: Influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res 51:2362-2365.
9. Doll R, Peto R. 1981. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191-1308.
10. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, Wingo PA, Jemal A, Feigal EG. 2002. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer 94:2766-2792.
11. Gensler HL, Magdaleno M. 1991. Topical vitamin E inhibition of immunosuppression and tumorigenesis induced by ultraviolet irradiation. Nutr Cancer 15:97-106.
12. Gensler HL, Aickin M, Peng YM, Xu M. 1996. Importance of the form of topical vitamin E for prevention of photocarcinogenesis. Nutr Cancer 26:183-191.
13. Gridley G, McLaughlin JK, Block G, Blot WJ, Gluch M, Fraumeni JF, Jr. 1992. Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 135:1083-1092.
14. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ, Lubet RL. 1995. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15:709-716.
15. Hagiwara A, Boonyaphiphat P, Tanaka H, Kawabe M, Tamano S, Kaneko H, Matsui M, Hirose M, Ito N, Shirai T. 1999. Organ-dependent modifying effects of caffeine, and two naturally occurring antioxidants alpha-tocopherol and n-tritriacontane-16,18-dione, on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary and colonic carcinogenesis in female F344 rats. Jpn J Cancer Res 90:399-405.
16. Hiroshino H, Tanooka H. 1979. Caffeine enhances skin tumor induction in mice. Toxicol Lett 4:83-85.
17. Huang M-T, Xie J-G, Wang Z-Y, Ho C-T, Lou Y-R, Wang C-X, Hard GC, Conney AH. 1997. Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: Demonstration of caffeine as a biologically important constituent of tea. Cancer Res 57:2623-2629.
18. Kim DJ, Han BS, Ahn B, Hasegawa R, Shirai T, Ito N, Tsuda H. 1997. Enhancement by indole-3-carbinol of liver and thyroid gland neoplastic development in a rat medium-term multiorgan carcinogenesis model. Carcinogenesis 18:377-381.
19. Kline K, Sanders BG. 1989. Modulation of immune suppression and enhanced tumorigenesis in retrovirus tumor challenged chickens treated with vitamin E. In Vivo 3:161-166.
20. Knekt P. 1991. Role of vitamin E in the prophylaxis of cancer. Ann Med 23:3-12.
21. Knekt P, Aromaa A, Maatela J, Aaran RK, Nikkari T, Hakama M, Hakulinen T, Peto R, Teppo L. 1991. Vitamin E and cancer prevention. Am J Clin Nutr 53:283S-286S.
22. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. 2000. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85.
23. Lin L, Yang F, Ye Z, Xu E, Yang C, Zhang C, Wu D, Nebert DW. 1991. Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: A protective effect. Pharmacogenetics 1:79-85.
24. Lippman SM, Hong WK. 2001. Molecular markers of the risk of oral cancer. N Engl J Med 344:1323-1326.
25. Lippman SM, Hong WK. 2002. Cancer prevention science and practice. Cancer Res 62:5119-5125.
26. Lou Y-R, Lu Y-P, Xie J-G, Huang M-T, Conney AH. 1999. Effects of oral administration of tea, decaffeinated tea, and caffeine on the formation and growth of tumors in high-risk SKH-1 mice previously treated with ultraviolet B light. Nutr Cancer 33:146-153.
27. Lu Y-P, Lou Y-R, Xie J-G, Peng Q-Y, Liao J, Yang CS, Huang M-T, Conney AH. 2002. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 99:12455-12460.
28. McIntosh GH. 1992. The influence of dietary vitamin E and calcium status on intestinal tumors in rats. Nutr Cancer 17:47-55.
29. Minton JP, Abou-Issa H, Foecking MK, Sriram MG. 1983. Caffeine and unsaturated fat diet significantly promotes DMBA-induced breast cancer in rats. Cancer 51:1249-1253.
30. Mitchel RE, McCann R. 1993. Vitamin E is a complete tumor promoter in mouse skin. Carcinogenesis 14:659-662.
31. Nagasawa H, Konishi R. 1988. Stimulation by caffeine of spontaneous mammary tumorigenesis in mice. Eur J Cancer Clin Oncol 24:803-805.
32. Neuhouser ML, Patterson RE, Thornquist MD, Omenn GS, King IB, Goodman GE. 2003. Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of β-carotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomarkers Prev 12:350-358.
33. Nitta Y, Kamiya K, Tanimoto M, Sadamoto S, Niwa O, Yokoro K. 1991. Induction of transplantable tumors by repeated subcutaneous injections of natural and synthetic vitamin E in mice and rats. Jpn J Cancer Res 82:511-517.
34. Nomura T. 1976. Diminution of tumorigenesis initiated by 4-nitroquinoline-1-oxide by post-treatment with caffeine in mice. Nature 260:547-549.
35. Nomura T. 1980. Timing of chemically induced neoplasia in mice revealed by the antineoplastic action of caffeine. Cancer Res 40:1332-1340.
36. Nomura T. 1983. Comparative inhibiting effects of methylxanthines on urethan-induced tumors, malformations, and presumed somatic mutations in mice. Cancer Res 43:1342-1346.
37. Odukoya O, Hawach F, Shklar G. 1984. Retardation of experimental oral cancer by topical vitamin E. Nutr Cancer 6:98-104.
38. 1-initiated hepatocarcinogenesis: Results from a 9,000 animal tumor study. Carcinogenesis 20:453-458.
39. Omenn GS. 1998. Chemoprevention of lung cancer: The rise and demise of beta-carotene. Annu Rev Public Health 19:73-99.
40. Peraino C, Fry RJ, Staffeldt E. 1971. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2- acetylaminofluorene. Cancer Res 31:1506-1512.
41. Perchellet JP, Boutwell RK. 1981. Effects of 3-isobutyl-1-methylxanthine and cyclic nucleotides on the biochemical processes linked to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 41:3927-3935.
42. Perchellet JP, Owen MD, Posey TD, Orten DK, Schneider BA. 1985. Inhibitory effects of glutathione level-raising agents and D-alpha-tocopherol on ornithine decarboxylase induction and mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 6:567-573.
43. Pott P. 1775. Chirurgial observations relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures, and the mortification of the toes and feet, Chirurgial Works of Percivall Pott, F.R.S. and Surgeon to St. Bartholomew's Hospital London: L. Hawes, W. Clark and R. Collins. pp 734-736.
44. Potter JD, Goode E, Morimoto L. 2003. AACR special conference: The molecular and genetic epidemiology of cancer. Cancer Epidemiol Biomarkers Prev 12:803-805.
45. Redmond DE. 1970. Tobacco and cancer: The first clinical report, 1761. N Engl J Med 282:18-23.
46. Rothwell K. 1974. Dose-related inhibition of chemical carcinogenesis in mouse skin by caffeine. Nature 252:69-70.
47. Sabichi AL, Demierre M-F, Hawk ET, Lerman CE, Lippman SM. 2003. Frontiers in cancer prevention research. Cancer Res 63:5649-5655.
48. Slaga TJ, Bracken WM. 1977. The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase. Cancer Res 37:1631-1635.
49. Stoner G, Casto B, Ralston S, Roebuck B, Pereira C, Bailey G. 2002. Development of a multi-organ rat model for evaluating chemopreventive agents: Efficacy of indole-3-carbinol. Carcinogenesis 23:265-272.
50. Theiss JC, Shimkin MB. 1978. Inhibiting effect of caffeine on spontaneous and urethan-induced lung tumors in strain A mice. Cancer Res 38:1757-1761.
51. VanderPloeg LC, Welsch CW. 1991. Inhibition by caffeine of ovarian hormone-induced mammary gland tumorigenesis in female GR mice. Cancer Lett 56:245-250.
52. Verma AK, Shapas BG, Rice HM, Boutwell RK. 1979. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion. Cancer Res 39:419-425.
53. Verma AK, Conrad EA, Boutwell RK. 1982. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Cancer Res 42:3519-3525.
54. Wang Z-Y, Huang M-T, Lou Y-R, Xie J-G, Reuhl KR, Newmark HL, Ho C-T, Yang CS, Conney AH. 1994. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res 54:3428-3435.
55. Wattenberg LW, Loub WD. 1978. Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles. Cancer Res 38:1410-1413.
56. Welsch CW, Scieszka KM, Senn ER, DeHoog JV. 1983. Caffeine (1,3,7-trimethylxanthine), a temperature promoter of DMBA-induced rat mammary gland carcinogenesis. Int J Cancer 32:479-484.
57. Welsch CW, DeHoog JV, O'Conner DH. 1988. Influence of caffeine consumption on carcinomatous and normal mammary gland development in mice. Cancer Res 48:2078-2082.
58. Weyant MJ, Carothers AM, Mahmoud NN, Bradlow HL, Remotti H, Bilinski RT, Bertagnolli MM. 2001. Reciprocal expression of ERα and β is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res 61:2547-2551.
59. Willett W. 1998. Diet nutrition and the prevention of cancer. In: Shils ME, Olson JA, Shike M, Ross AC, editors. "Modern nutrition in health and disease, 9th edn." Baltimore: Williams and Wilkins. pp 1243-1253.
60. 3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin. Biochem Biophys Res Commun 116:605-611.
61. 3 on the formation of skin tumors in mice treated chronically with 7,12-dimethylbenz[a]anthracene. Biochem Biophys Res Commun 130:924-931.
62. Writing Group for the Women's Health Initiative Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 288:321-333.
63. Xu M, Orner GA, Bailey GS, Stoner GD, Horio DT, Dashwood RH. 2001. Post-initiation effects of chlorophyllin and indole-3-carbinol in rats given 1,2-dimethylhydrazine or 2-amino-3-methyl-imidazo[4,5-f]quinoline. Carcinogenesis 22:309-314.
64. Zajdela F, Latarjet R. 1978. Ultraviolet light induction of skin carcinoma in the mouse; influence of cAMP modifying agents. Bull Cancer (Paris) 65:305-313.